z-logo
open-access-imgOpen Access
Reply: Platelet-derived growth factor-BB may be involved in mesenchymal stem cell secretome-induced neuroprotection of retinal ganglion cells
Author(s) -
Thomas V. Johnson,
Keith R. Martin,
Stanislav I. Tomarev
Publication year - 2014
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awu011
Subject(s) - mesenchymal stem cell , neuroprotection , microbiology and biotechnology , retinal , transplantation , stem cell , retinal ganglion cell , platelet derived growth factor , growth factor , platelet derived growth factor receptor , biology , immunology , optic nerve , cancer research , medicine , neuroscience , ophthalmology , biochemistry , receptor
Sir, We are grateful for the opportunity to respond to the correspondence from Dr He, and we thank the author for his interest in our recent article, which demonstrated that platelet-derived growth factor (PDGF) is secreted by bone marrow-derived mesenchymal stem cells (MSCs) and confers neuroprotection to retinal ganglion cells in organotypic retinal explant culture and in an in vivo model of ocular hypertensive glaucoma (Johnson et al. , 2013). Based on our previously reported observation that intravitreal MSC transplantation confers optic nerve neuroprotection (Johnson et al. , 2010), we recently analysed the human MSC secretome and compared it to that of human fibroblasts using xMAP antibody-based arrays. As Dr He noted, we demonstrated that PDGF-AA secretion from MSCs was >500-fold greater than from fibroblasts, …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom